Studiile confirmă că medicamentele GLP-1 precum Ozempic pot cauza căderea părului în situații rare

Recent studies indicate that GLP-1 medications, such as Ozempic, may lead to hair loss in rare cases, with a higher risk compared to other diabetes drugs. The likelihood of receiving a new alopecia diagnosis was found to be 37% greater for GLP-1 users than for SGLT-2 users, and 68% higher than for DPP-4 inhibitors. However, the actual incidence of alopecia remains low, with 3 to 9 cases per 1,000 individuals annually. Additional research suggests that tirzepatide users face a higher risk of alopecia than those on semaglutide. Experts emphasize the need for personalized monitoring and counseling regarding hair loss and weight loss.